Preparing for a Cell and Gene Future | Episode 1: Looking Back at 2023 Achievements

This episode is the first of our new 2024 series – Preparing for a Cell and Gene Future. In this episode, we take a look back at a banner year for cell and gene therapies and what to expect in 2024 in terms of next-generation therapies and gene editing progress with Chris Learn, Senior Vice President and Head of the Cell and Gene Center of Excellence.


Return to Insights Center

Related Insights


CAR-T product development: an assessment of FDA’s final guidance for industry

Feb 27, 2024


CAR-T boxed warnings: regulatory precedents and opportunities

Feb 9, 2024


How we can bring gene therapies to bear on diseases of aging

Jan 31, 2024


New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023


Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success

Mar 28, 2023


The New Frontier of Innovative Therapies: Navigating What's Next

Jan 12, 2023


Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit

Sep 19, 2022


SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

Aug 24, 2022


Cell & Gene Therapies: A Regulatory Update

Jul 22, 2022


Chris Learn joins Parexel as Head of the Cell and Gene Center of Excellence

Apr 4, 2022


Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021


Regulatory, clinical and logistics challenges of ATMPs in clinical research

Apr 22, 2021